Food and Drug Administration, Dockets Management Branch, 5630 Fishers Lane - Room 1061- HFA-305, Rockville, MD, 20852; 301-827-6860; Fax 301-827-6870; TTY/TDD Users 1-800-735-2258 - [E-mail Us]

DOCKETS ENTERED on 12/04/02

TABLE OF CONTENTS

Hyper links are part of the Docket  title - not all dockets/documents are linked

NOTE:  Documents received by the Dockets Management Branch "MAY" be posted on the Internet. PLEASE DO NOT include personal identifying information, i.e. date of birth, social security number, etc., in your correspondence.

[FDA DOCKETS PAGE] [FDA HOME PAGE]  [ ITEM CODES ]

 
77N-094I Internal, Analgesic, Antipyretic, and Antirheumatic Drug Pro *
00D-1539 Electronic Records & Signatures, Retention of Electronic Rec *
00N-1571 Enrofloxacin for Poultry: Opportunity for hearing *
02D-0325 Polyvinychloride using Plasticier di-(2-ethyhexyl)phthalate *
02P-0450 Withhold Approval of ANDA for Amino Acid Solution Drug Prod. *
02P-0503 ANDA abbreviated new drug application for Digoxin Elixir, *

77N-094I Internal, Analgesic, Antipyretic, and Antirheumatic Drug Pro

EXT 2 Albemarle Corp. Vol#: 1

90N-0056 Parenteral Drug Prod. Containing Aluminum as an Ingredient

NFR 3 Vol#: 4

94D-0147 Utility Study Anti-Salmonella Chemical Food Adds in Feeds

GDL 2 Guidance Vol#: 1

NAD 2 Vol#: 1

00D-1539 Electronic Records & Signatures, Retention of Electronic Rec

C 5 Purdue Pharma L.P. Vol#: 7

C 6 Amgen Inc. Vol#: 7

C 7 SEC Associates, Inc. Vol#: 7

C 8 Merck & Co., Inc. Vol#: 7

C 9 Bayer Vol#: 7

C 10 Schering-Plough Vol#: 7

C 11 PhRMA Vol#: 7

00N-1571 Enrofloxacin for Poultry: Opportunity for hearing

CS 19 HFA-305 Vol#: 329

OR 20 HF-3 Vol#: 329

00P-1378 Cosmetic Products Containing Alpha Hydroxy Acids

GDL 1 Guidance for Industry Vol#: 1

01D-0503 Filth from Insects,Rodents & other Pests in Food

GDL 2 Guidance for FDA Staff & Industry Vol#: 1

NAD 2 Vol#: 1

02D-0325 Polyvinychloride using Plasticier di-(2-ethyhexyl)phthalate

C 13 American Chemistry Council Vol#: 1

C 14 Medical Device Manufacturers Assn (MDMA) Vol#: 1

C 15 AdvaMed Vol#: 1

C 16 American Red Cross Vol#: 1

02N-0159 Focus Groups as used by the Food and Drug Administration

NAL 1 Vol#: 1

02N-0273 Animal Proteins Prohibited in Ruminant Feed

NPR 2 Vol#:

02N-0451 Withdrawal of 20 Guidances on Individual Product Labeling

NWL 1 Vol#: 1

02N-0466 Safety, Clinical and Immune Response of Dryvax

EMC 229 Jennifer Zint Vol#: 1

EMC 230 Susan Wallace Vol#: 1

EMC 231 Jeff Brasher Vol#: 1

EMC 232 No signature Vol#: 1

EMC 233 No signature Vol#: 1

EMC 234 Lori Boldt Vol#: 1

EMC 235 Susan Schaefgen Vol#: 1

EMC 236 Lolita Cook Vol#: 1

EMC 237 Gina Fleming Vol#: 1

EMC 238 No signature Vol#: 1

EMC 239 Jeffrey Robshaw Vol#: 1

EMC 240 Dr. Corey Cameron-Cooper Vol#: 1

02N-0486 Prescription Drug Marketing Act of 1987

N 1 Vol#: 1

02P-0450 Withhold Approval of ANDA for Amino Acid Solution Drug Prod.

C 1 King & Spaulding Vol#: 1

02P-0503 ANDA abbreviated new drug application for Digoxin Elixir,

ACK 1 HFA-305 Vol#: 1

CP 1 Roxane Laboratories Vol#: 1

02V-0504 Laser Light Show

ACK 1 HFA-305 Vol#: 1

VAR 1 Swinomish Northern Lights Casino Vol#: 1